5 takeaways from AP's report on the big backlog of uninspected drug factoriesNearly five years after COVID-19, a new analysis by The Associated Press shows that U.S. regulators are struggling to address a massive backlog of uninspected pharmaceutical plants9/5/2024 09:16:04 EDT
No comments